Cyclobenzaprine Hydrochloride Drug For Further Processing - NDC Database

NDC Database
Adare Pharmaceuticals, Inc.Aurobindo Pharma Limited
Cyclobenzaprine Hydrochloride Drug For Further Processing

Cyclobenzaprine Hydrochloride Drug For Further Processing

National Drug Code (NDC) records including drug products, labelers, dosage forms, strengths, substances and marketing information.

DRUG FOR FURTHER PROCESSING
Last Marketing Date
2009-05-12
Data Source
FDA
First Marketing Date
2008-09-26
Advertise Here
Reach qualified buyers

Boost your visibility among pharma sourcing professionals and potential buyers.

  • Grow your business with qualified leads
  • GDS reports on your ad performance
  • Targeted to this product's audience
  • Direct enquiries from buyers
  • Visibility to pharma professionals
Buy This Ad Space
NDC Records Timeline (4 records)
Clear
2009
12 May
Adare Pharmaceuticals, Inc.
DRUG FOR FURTHER PROCESSING

NDC

59917-090

Labeler

Adare Pharmaceuticals, Inc.

Nonproprietary Name

Cyclobenzaprine Hydrochloride

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

CAPSULE, EXTENDED RELEASE

Strength

15 mg/1

Start Marketing: 2009-05-12

Substance

CYCLOBENZAPRINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2009-05-12

End Marketing Date

-

Listing / Certification

2026-12-31

2009
12 May
Adare Pharmaceuticals, Inc.
DRUG FOR FURTHER PROCESSING

NDC

59917-091

Labeler

Adare Pharmaceuticals, Inc.

Nonproprietary Name

Cyclobenzaprine Hydrochloride

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

CAPSULE, EXTENDED RELEASE

Strength

30 mg/1

Start Marketing: 2009-05-12

Substance

CYCLOBENZAPRINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2009-05-12

End Marketing Date

-

Listing / Certification

2026-12-31

2008
26 Sep
DRUG FOR FURTHER PROCESSING

NDC

65862-190

Labeler

Aurobindo Pharma Limited

Nonproprietary Name

Cyclobenzaprine Hydrochloride

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

TABLET, FILM COATED

Strength

5 mg/1

Start Marketing: 2008-09-26

Substance

CYCLOBENZAPRINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2008-09-26

End Marketing Date

-

Listing / Certification

2026-12-31

2008
26 Sep
DRUG FOR FURTHER PROCESSING

NDC

65862-191

Labeler

Aurobindo Pharma Limited

Nonproprietary Name

Cyclobenzaprine Hydrochloride

Marketing Category

DRUG FOR FURTHER PROCESSING

Dosage Form

TABLET, FILM COATED

Strength

10 mg/1

Start Marketing: 2008-09-26

Substance

CYCLOBENZAPRINE HYDROCHLORIDE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2008-09-26

End Marketing Date

-

Listing / Certification

2026-12-31

Limited-Time Offer
Advertise on PharmaJungle - Free for 30 Days

Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.

  • 30 days of free advertising
  • Visibility across all pages
  • Performance report with ad insights
  • No setup or registration fee
Claim Your Free Ad

Exclusive introductory offer for new advertisers

Related Databases
2 of 6 have records
Japan DMF 1 NDC Database 26
EDQM CEP No records
KDMF No records
FDA Approved Drugs Database No records
Drug Prices in Switzerland No records
Product Type Breakdown
4 total
  • DRUG FOR FURTHER PROCESSING
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Substance

CYCLOBENZAPRINE HYDROCHLORIDE

Identifiers

NDC: 59917-090
DEA Schedule:

Official FDA Data

Based on publicly available FDA NDC information

National Drug Code

Structured NDC product information

Product Information

Drug, labeler and marketing data

Easy to Explore

Search and filter NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.
PharmaJungle
Buying request

Post your requirement

Get offers from suppliers

  • Reach pharmaceutical suppliers
  • Specify quality standard and quantity
  • Set your shipping preference
  • Receive offers directly
  • Listed on our marketplace

Your product details and requirements may be published on the marketplace.

PharmaJungle

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.